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Critical illness can lead to cognitive impairments. 1 Survivors of critical illness are often found to have severe cognitive impairments, with numerous studies reporting cognitive impairment in > 50% of Intensive Care Unit (ICU) survivors. 1 Cognitive dysfunction correlates negatively with quality of life and might interfere with the ability to live independently. 2 Maintaining cognitive function is crucial for patients when accepting a course of treatment. 3 Reasons for cognitive impairments following critical illness are likely numerous -e.g. sedatives, cerebral hypoperfusion, hypoxia, delirium or immobility, and are not yet fully elucidated. [4] [5] [6] [7] [8] Likewise, effective treatment has not been established. 9 Impaired cognitive function constitutes a third of the Post-Intensive Care Syndrome (PICS), alongside mood disorders (posttraumatic stress, depression, anxiety) and impaired physical function. 10 Several reviews have created an overview over interventions to prevent posttraumatic stress [11] [12] [13] or impaired physical function. [14] [15] [16] [17] [18] To the best of our knowledge no previous systematic review has dealt with interventions aimed at improving cognitive function in survivors of critical illness. Focus on the area is currently growing, and a number of interesting clinical studies are available.
The aim of this review was to create a summary of the current evidence concerning clinical interventions during ICU-admission to reduce cognitive impairment in survivors of critical illness. The study hypothesis was that clinical interventions during ICU-admission can reduce cognitive impairments following critical illness.
Methods
This review was reported according to the PRISMA principles. 19 The protocol was published at PROSPERO 20 (registration ID: CRD42016036389).
Search strategy
We searched MEDLINE, EMBASE, Cinahl, The Cochrane Library and PsycINFO (from 1980 to 2016, April) using relevant terms concerning critical illness and cognitive dysfunction. The exact search is accessible as supplemental material. Via the MeSH database and the EMTREE thesaurus we identified relevant search terms. To evaluate the adequacy of our search strategy we used the Capture-MarkRecapture technique. 21 Additionally, reference lists of included studies were hand-searched to check for other potentially relevant publications.
Study selection
Inclusion criteria:
• Reporting on adult patients (18 years or above) • Reporting on critically ill patients, admitted to an ICU • Reporting on an intervention (pharmacological or non-pharmacological) intended on affecting cognitive function at or after discharge. The intervention should be initiated during ICUadmission and could be continued after discharge.
• Reporting on an objective, validated evaluation of cognitive function.
Exclusion criteria: • Language other than English or Danish • Unpublished data • Reviews • Studies reporting solely on survivors of traumatic brain injury, stroke or cardiac arrest Two authors (HKN and HIJ) independently assessed title, abstract and (if necessary) full text for eligibility using the Covidence software. 22 If disagreements arose, it was resolved by discussion including the third author (PT).
Outcomes
The primary outcome was the effect of a given intervention on cognitive function at or after ICUdischarge. Assessment using any validated questionnaire or clinical test would be considered.
The secondary outcome was health related quality of life at or after ICU-discharge. Assessment using any validated questionnaire or interview-guide would be considered.
No analyses of subgroups were planned.
Data extraction
Two authors (HKN and HIJ) independently extracted data using a predefined data collection Acta Anaesthesiologica Scandinavica 61 (2017) 135-148
form. Data extracted was: study ID, design, setting, number of patients, in-and exclusion criteria, baseline characteristics, details on intervention and follow-up assessment, neuropsychological tests used, details on outcomes and results, data on quality of life (if applicable). If any data were found to be missing, authors were contacted in an attempt to obtain them.
Quality assessment
A wide variety of interventions were found due to the broad aim of this review. Therefore it was not appropriate to evaluate evidence on an outcome level, as it would not make sense to compare outcomes in a pooled group of patients, having been exposed to for example different nutritional strategies or early mobilization. Study quality was therefore evaluated on study level based on the GRADE approach, 23 including: design (randomised or not), study limitations (loss to follow-up, risk of bias, power calculations performed), precision (sample size) and directness (whether cognition was the primary outcome, i.e. was the intervention targeted at affecting cognitive function), resulting in an overall judgement made by the authors of quality in very low, low, moderate or high. Risk of bias assessment was undertaken for randomized trial as described in the Cochrane Handbook 24 and for non-randomized trials using the Cochrane Collaborations ROBINS-I tool. 25 Details of the risk of bias evaluations for each study can be found as supplemental material.
Results
The systematic literature search identified 6.322 titles, 4.877 of which were unique (Fig. 1) . The search details are presented in the Appendix S1. Two reviewers (HKN, HIJ) screened reference The studies identified were few and heterogeneous with regard to both type of intervention, timing of follow-up and methods for cognitive assessment. Metaanalysis was therefore not undertaken. Table 1 shows study characteristics. All trials were conducted in USA within the last 10 years, the majority within the last five. Six trials were randomized clinical trials [26] [27] [28] [29] [30] [31] and one was a non-randomized pre-and post-interventional study. 32 The numbers of included patients were fairly similar throughout the trials (72-266 patients). The participants were relatively homogeneous; they came mainly from medical ICU's, had comparable disease severities, a fairly equal age-and gender distribution and the majority was mechanically ventilated. Table 2 describes quality of included studies. Many of the included studies were found to have study limitations in form of high loss to follow-up and no specific power calculation for cognitive function. Likewise, many of the studies were affected by indirectness, since cognitive function rarely was a primary outcome. All randomised studies were judged to have a low risk of bias (details can be found in Supporting information). Strict exclusion criteria were applied in all studies, reflected in the relative low number of patients included out of the number screened, and in many studies leading to small sample sizes. Due to these limitations, none of the studies were rated as high quality with respect to assessing effect of interventions on cognitive function after ICU-discharge. We judged two of the studies to be of moderate quality. 27, 32 Five studies were of low quality; one because of a non-randomized design and the accompanying moderate risk of bias, 32 the other four were downgraded because of study limitations (higher loss to follow-up) imprecision (smaller sample sizes) than the studies deemed to be of moderate quality. [28] [29] [30] [31] Detailed assessment of bias in these studies is presented in the Appendix S2.
The interventions evaluated proved to be very heterogeneous, encompassing nutritional strategies, 26 fluid management strategies, 30 sedation medications, 29 a sedation interruption and combined weaning strategy, 31 the use of a statin, 27 a sleep-quality improvement, 32 and a combination of early physiotherapy and cognitive therapy 28 ( Table 3 ). All interventions were initiated early during admission/mechanical ventilation; two interventions were continued after discharge. 27, 28 Outcome assessment was performed between ICU-discharge and 12 months after. A wide span and differing numbers of validated neuropsychological tests were used. In one study the same neuropsychologist examined all participants 31 ; three studies had two assessors who were nonneuropsychologists, 28, 30, 32 and three studies used multiple assessors, also non-neuropsychologists. 26, 27, 29 Four studies performed the neuropsychological testing face to face, either in hospitals, research clinics, healthcare facilities or patients homes. 28, 29, 31, 32 One study performed all tests via telephone, as this was their specific intent. 30 Two studies did both, to a varying extent. 26, 27 One trial, assessing a daily awakening and breathing controlled trial, found that fewer patients in the intervention group had cognitive impairments 3 months post-discharge, but found no difference in composite cognitive scores, and no difference at all 12 months post-discharge. 31 One study found, at 12 months, a negative effect on cognitive function of their intervention, a conservative fluid strategy. 30 All in all, none of the evaluated interventions were found to have a significant positive effect on cognitive function.
Only two studies reported on the effect of their intervention on quality of life 28, 31 (Table 4) . Both studies provided data at 3 months post-discharge, and one additionally at 12 months. 31 Quality ratings (Table 2) were performed with regard to cognitive outcome, but comparable circumstances applied to this outcome, hence quality ratings could be considered applicable. None of the interventions were found to have a significant effect on quality of life.
Discussion
This topical systematic review aimed at creating an overview of the current evidence on the field Another trial, testing a conservative fluid strategy, found a significantly worse cognitive function in their intervention group. 30 The latter should be interpreted with care however, since the trial was not designed or powered to detect a difference in cognitive function and loss to follow-up was high. Finally, this study reported baseline imbalances potentially introducing bias (higher disease severity score in the control group). In total, none of the tested interventions were found to significantly reduce cognitive impairments after ICU-discharge.
A number of factors limit the overall completeness, quality and applicability of the evidence. Factors to affect quality in the included studies were small sample sizes, causing imprecision, and study limitations, such as high loss to follow-up. Few trials have been conducted on the area and even fewer with an intervention and design specifically intended to reduce cognitive impairments, which affects quality due to indirectness. Since the interventions in the included studies were very diverse, only few patients have been exposed to each intervention. Furthermore, most trials included a low number of patients out of the number screened, mainly due to strict exclusion criteria. When applying strict exclusion criteria, researchers aim at creating a homogenous group of subjects without for example preexisting cognitive impairment or substance abuse. This carries a risk of compromising generalizability of results, since the average patient in an ICU is not a healthy, young person without abuse or cognitive impairment. On the other hand, including a broad range of 'representative' critically ill patients will quite likely complicate long-term assessment, introducing the risk of a high loss to follow-up. This is a difficult balance that researchers must consider carefully when planning a clinical trial. Publication bias is difficult to evaluate within this field. The included studies have, fortunately, been published even though they did not demonstrate a positive effect of their interventions on cognitive impairments. It is unlikely that much unpublished data on clinical interventions that significantly reduce cognitive impairments following critical illness exists, however there may be unpublished studies on various clinical interventions which showed no or a negative effect.
The timing of interventions is likely to have an effect. Should the intervention be initiated early or late during admission, during mechanical ventilation, and should it be continued after discharge? Based on the current evidence, these questions cannot be answered. The included pilot-study by Brummel et al. 28 demonstrates that the ambitious intervention 'early cognitive mobilization' is feasible. However, their number of drop outs in the physical + cognitive therapy intervention group underlines that it is not easy, and demands can exceed resources in the frail ICU-patients and -survivors.
Likewise, the timing of follow-up assessment is likely to be important. In the included studies, follow-up occurred exclusively within the first year, with 12 months post-discharge being the most frequent time point (four studies 26, 27, 30, 31 ). In reviews, the prevalence of cognitive impairment in survivors of critical illness has been found to be above 70% at discharge, 13-79% at 3-6 months, 10-79% at 1 year, 25-47% at 2 years and approximately 25% at 6 years post-discharge. 33, 34 However, the authors of the reviews found it difficult to make conclusions across studies due to large variations in tests used, conduct of follow-up, definitions of impairment etc. It does seem, however, that a general improvement might occur within the first year, with no convincing improvement from 1 to 2 years. 33, 35 Data beyond 2 years should be interpreted cautiously, since they are based on small and retrospective studies. 34 Hence, the optimal time for cognitive assessment following critical illness has not been established. Future studies should ideally prospectively assess larger samples, within the first year and after for example 2 and 5 years, but we acknowledge the inherent logistical and economical challenges. Considering the conduct of follow-up, only one trial had the same person test all subjects, even though it is known that making conclusions on neuropsychological function is difficult and prone to interrater variability, even for trained neuropsychologists. 36 The number of outcome assessors is obviously dictated by economy and logistics, since it would complicate matters greatly if one neuropsychologist had to assess every subject in a large multinational trial. In large trials, an option could be to perform subgroup analyses on how data was collected (interview, telephone) and investigate the interrater reliability of a trial's multiple outcome assessors. The use of questionnaires in the assessment of cognitive function is not advisable, since it has been thoroughly demonstrated that there is little correlation between patients' own reporting of cognitive impairment and results of objective neuropsychological testing. 37, 38 Patients experiencing delirium during ICUadmission often have poor cognitive function after discharge. [39] [40] [41] [42] Based on existing evidence, the exact relationship between delirium and long-term cognitive function, and specifically causality, cannot be determined. However, it seems plausible that interventions (such as early mobilization, sleep promotion etc.) successfully reducing delirium could have a positive effect on cognition. As recently stated by Girard and colleagues, we need large randomized trials that examine the effects of interventions on both delirium in the ICU and long-term cognitive outcomes. 8 One of the included trials argues that neurocognitive testing can be done via telephone, 30 which would enable follow-up in larger populations, e.g. multicenter trials over large distances, without involving numerous investigators. However, caution should be taken when choosing to perform neurocognitive testing via telephone, as it complicates assessment of some cognitive domains, such as visuospatial function.
Three of the included studies used the same definition of 'cognitive impairment': either 1.5 SD or more below population mean on two or more tests, or 2 SD or more below mean on one or more tests. 26, 27, 31 One study defines impairment in a single domain as a score greater than 2 SD below the population, 30 one study operates with 'mild-to-moderate' (if ≥ 1 and < 2 SD below norm) and 'severe' impairment (if ≥ 2 SD below norm), 32 and two studies do not use a formal definition. 28, 29 For the sake of future research and to facilitate synthesis of evidence in future systematic reviews, this lack of consensus on a definition of cognitive impairment is a challenge.
It must be kept in mind that comparing a population of critical illness survivors to the background population is a complex matter, since studies indicate that patients, who are admitted to ICUs might differ from the background population already pre-morbidly. [43] [44] [45] Establishing pre-morbid function is difficult owing to the acute nature of critical illness, and large cohort studies are needed to make prospective assessments possible. 46 Research on cognitive function following critical illness is feasible and highly relevant. However, quite a limited number of researches are currently engaged in the field, as there is a large overlap of authors on the included studies, and all studies took place in USA. It could prove to be very informative if more researches worldwide became involved.
This review has limitations. Although care has been taken to conduct a thorough literature search and a relatively high number of titles and abstracts were screened, relevant studies could inadvertently have been missed. We applied language restrictions, and this could also have caused an exclusion of relevant material, although the number of titles excluded from the search when filtering for language was less than 3% (data not shown). The focus of this review was to assess the effect of interventions commenced during ICU-admission. It might be that this is not the optimal timing of an intervention to minimize cognitive impairments. Thorough investigation of post-discharge interventions is warranted, and interesting data from recent trials are available. 47, 48 Seven clinical studies on interventions to reduce cognitive impairment were identified. None of them reported significant reductions in cognitive impairment. Quality was affected by study limitations, imprecision and indirectness in evidence. We conclude that there is not yet have enough evidence to make clinical decisions concerning interventions to reduce cognitive impairments following critical illness. However, the included studies show that research on cognitive function following critical illness is feasible, though large, well designed trials with a specific aim at reducing cognitive impairments are needed.
